NeuroInitiative, founded with the mission to advance research and understanding of neurodegenerative disorders, focuses on Alzheimer's and Parkinson's diseases. The company leverages cutting-edge scientific and technological capabilities to create a four-dimensional navigation system of pathways inside neurons. This innovative computer simulation aims to simplify, unravel, and enhance the understanding of neuronal complexity, providing researchers with powerful tools to study these debilitating conditions.
Notable affiliated individuals and investors include experts in neuroscience and technology sectors, though specific names are not disclosed. NeuroInitiative has achieved significant milestones in developing its 4D neuron simulation technology, which has shown great promise in aiding researchers. The company's impact is marked by its potential to revolutionize the study of neurodegenerative diseases, offering new insights and accelerating the development of effective treatments.
Quick Facts
When was NeuroInitiative's last funding round?
NeuroInitiative's most recent funding round was for $1M (USD) in November 2017.
How much disclosed funding has NeuroInitiative raised?
As of Nov 15, 2017, NeuroInitiative has disclosed funding of $1M (USD).